These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 13678553)

  • 1. Pharmacotherapy for schizophrenia and co-occurring substance use disorders.
    Noordsy DL; Green AI
    Curr Psychiatry Rep; 2003 Oct; 5(5):340-6. PubMed ID: 13678553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for schizophrenia and co-occurring substance use disorders.
    Green AI
    Neurotox Res; 2007 Jan; 11(1):33-40. PubMed ID: 17449446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of schizophrenia and co-occurring substance use disorders.
    Smelson DA; Dixon L; Craig T; Remolina S; Batki SL; Niv N; Owen R
    CNS Drugs; 2008; 22(11):903-16. PubMed ID: 18840032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia.
    Buckley PF
    J Subst Abuse Treat; 1998; 15(2):113-6. PubMed ID: 9561949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of schizophrenia and comorbid substance use disorder.
    Green AI; Salomon MS; Brenner MJ; Rawlins K
    Curr Drug Targets CNS Neurol Disord; 2002 Apr; 1(2):129-39. PubMed ID: 12769622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion and smoking cessation.
    Evins AE; Tisdale T
    Am J Psychiatry; 1999 May; 156(5):798-9. PubMed ID: 10327924
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
    Green AI
    J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.
    Moore TA; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Robinson DG; Schooler NR; Shon SP; Stroup TS; Miller AL
    J Clin Psychiatry; 2007 Nov; 68(11):1751-62. PubMed ID: 18052569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo controlled trial of bupropion for smoking cessation in schizophrenia.
    George TP; Vessicchio JC; Termine A; Bregartner TA; Feingold A; Rounsaville BJ; Kosten TR
    Biol Psychiatry; 2002 Jul; 52(1):53-61. PubMed ID: 12079730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
    Arranz B; Garriga M; García-Rizo C; San L
    Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders.
    Brunette MF; Drake RE; Xie H; McHugo GJ; Green AI
    Schizophr Bull; 2006 Oct; 32(4):637-43. PubMed ID: 16782758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance abuse and schizophrenia: pharmacotherapeutic intervention.
    Green AI; Noordsy DL; Brunette MF; O'Keefe C
    J Subst Abuse Treat; 2008 Jan; 34(1):61-71. PubMed ID: 17574793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse in schizophrenia: a review.
    Buckley PF
    J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?
    Green AI; Zimmet SV; Strous RD; Schildkraut JJ
    Harv Rev Psychiatry; 1999; 6(6):287-96. PubMed ID: 10370435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine treatment in patients with prior substance abuse.
    Kelly DL; Gale EA; Conley RR
    Can J Psychiatry; 2003 Mar; 48(2):111-4. PubMed ID: 12655909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine.
    Mesholam-Gately RI; Gibson LE; Seidman LJ; Green AI
    Schizophr Res; 2014 May; 155(1-3):45-51. PubMed ID: 24685823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of schizophrenia with comorbid substance use disorder.
    Azorin JM; Simon N; Adida M; Belzeaux R
    Expert Opin Pharmacother; 2016; 17(2):231-53. PubMed ID: 26635059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the relationship between schizophrenia and substance abuse?
    Green AI
    Harv Ment Health Lett; 2000 Oct; 17(4):8. PubMed ID: 11015759
    [No Abstract]   [Full Text] [Related]  

  • 19. Practice patterns of bupropion co-prescription with antipsychotic medications.
    Gautam M; Patel S; Zarkowski P
    J Addict Dis; 2022; 40(4):481-488. PubMed ID: 35068363
    [No Abstract]   [Full Text] [Related]  

  • 20. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.